Crescent Biopharma Financial Overview
Crescent Biopharma's market cap is currently $164.63M. The company's EPS TTM is $-1.27; its P/E ratio is -0.54; Crescent Biopharma is scheduled to report earnings on November 6, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
